ORCHPHARMA

Orchid Pharma Share PriceOrchid Pharma

₹570.2
6.1 (1.08%)
As on 30 November, 2023 | 05:41 BSE: 524372 NSE: ORCHPHARMAISIN: INE191A01027

Orchid Pharma Performance

Day Range

  • Low 564.00
  • High 581.00
₹ 570.2

52 Week Range

  • Low 332.75
  • High 634.80
₹ 570.2
  • Open Price568.80
  • Previous Close564.10
  • Volume180878

Start SIP in Orchid Pharma

Start SIP

Orchid Pharma Share Price

  • Over 1 Month 22.12%
  • Over 3 Month 4.46%
  • Over 6 Month 38.01%
  • Over 1 Year 42.18%

Orchid Pharma Key Statistics

P/E Ratio 30.1
PEG Ratio 0.1
Market Cap Cr 2,892
Price to Book Ratio 4.2
EPS 2.8
Dividend 0
Relative Strength Index 62.5
Money Flow Index 51.91
MACD Signal 15.63
Average True Range 26.98

Orchid Pharma Investment Rating

  • Master Rating:
  • Orchid Pharma has an operating revenue of Rs. 751.34 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 8% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 22%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 19% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 62 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Orchid Pharma Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 199183210160165131180
Operating Expenses Qtr Cr 175161170146147119151
Operating Profit Qtr Cr 24224014181229
Depreciation Qtr Cr 8878182227
Interest Qtr Cr 4678984
Tax Qtr Cr 0000000
Net Profit Qtr Cr 2011657-3-14-2
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 685566
Operating Expenses Annual Cr 582500
Operating Profit Annual in Cr 8457
Depreciation Cr 5532
Interest Annual Cr 3287
Tax Annual Cr 00
Net Profit Annual Cr 54-5
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1390
Cash from Investing Activity Annual Cr -27113
Cash from Financing Annual Activity Cr 31-217
Net Cash Flow Annual Cr 18-14
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 732678
Fixed Assets Annual Cr 619593
Total Non Current Assets Annual Cr 729659
Total Current Assets Annual Cr 494435
Total Assets Annual Cr 1,2231,094
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 179166
ROE Annual % 7-1
ROCE Annual % 54
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1512
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 199183210160165131178
Operating Expenses Qtr Cr 175161170146147119153
Operating Profit Qtr Cr 23224014181225
Depreciation Qtr Cr 8878182227
Interest Qtr Cr 4678984
Tax Qtr Cr 0000000
Net Profit Qtr Cr 209598-5-15-7
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 685569
Operating Expenses Annual Cr 582506
Operating Profit Annual in Cr 8453
Depreciation Cr 5587
Interest Annual Cr 3232
Tax Annual Cr 00
Net Profit Annual Cr 46-2
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1892
Cash from Investing Activity Annual Cr -31113
Cash from Financing Annual Activity Cr 31-217
Net Cash Flow Annual Cr 18-11
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 689647
Fixed Assets Annual Cr 620593
Total Non Current Assets Annual Cr 724661
Total Current Assets Annual Cr 501450
Total Assets Annual Cr 1,2251,111
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 169159
ROE Annual % 70
ROCE Annual % 6-3
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1511

Orchid Pharma Technicals

EMA & SMA

Current Price
₹570.2
6.1 (1.08%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹543.45
  • 50 Day
  • ₹526.64
  • 100 Day
  • ₹513.33
  • 200 Day
  • ₹482.34
  • 20 Day
  • ₹540.15
  • 50 Day
  • ₹514.10
  • 100 Day
  • ₹534.59
  • 200 Day
  • ₹473.30

Orchid Pharma Resistance and Support

PIVOT
₹571.74
Resistance
First Resistance 579.47
Second Resistance 588.73
Third Resistance 596.47
RSI 62.50
MFI 51.91
MACD Single Line 15.63
MACD 19.23
Support
First Resistance 562.47
Second Resistance 554.73
Third Resistance 545.47

Orchid Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 217,471 12,241,443 56.29
Week 649,172 46,136,672 71.07
1 Month 197,265 14,216,889 72.07
6 Month 69,106 5,823,567 84.27

Orchid Pharma Result Highlights

Orchid Pharma Synopsis

NSE-Medical-Diversified

Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 665.90 Cr. and Equity Capital is Rs. 40.82 Cr. for the Year ended 31/03/2023. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.
Market Cap 2,891
Sales 751
Shares in Float 1.42
No of funds 29
Yield
Book Value 3.18
U/D Vol ratio 1
LTDebt / Equity 20
Alpha 0.16
Beta 0.85

Orchid Pharma

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 72.4%72.4%89.96%89.96%
Mutual Funds 9.76%9.78%2.45%2.45%
Insurance Companies
Foreign Portfolio Investors 8.08%8.58%0.81%0.86%
Financial Institutions/ Banks 0.12%0.17%0.14%0.04%
Individual Investors 3.85%3.1%3.39%3.43%
Others 5.79%5.97%3.25%3.26%

Orchid Pharma Management

Name Designation
Mr. Ram Gopal Agarwal Chairman & Non-Exe.Director
Mr. Manish Dhanuka Managing Director
Mr. Mridul Dhanuka Whole Time Director
Mrs. Tanu Singla Independent Director
Dr. Dharam Vir Independent Director
Mr. Manoj Kumar Goyal Independent Director
Mr. Mudit Tandon Independent Director

Orchid Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Orchid Pharma Corporate Action

Date Purpose Remarks
2023-11-04 Quarterly Results
2023-08-10 Quarterly Results
2023-05-10 Audited Results
2023-02-09 Quarterly Results
2022-12-01 Others Inter alia, to consider and approve, amongst other things, raising of funds and issuance of securities through Qualified Institutions Placement basis.

Orchid Pharma MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 9,521
Nippon India Pharma Fund - Growth 5,539
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3,271
Quant Multi Asset Fund Growth 1,051
Quant Value Fund Regular Growth 767

Orchid Pharma FAQs

What is Share Price of Orchid Pharma ?

Orchid Pharma share price is ₹570 As on 30 November, 2023 | 05:27

What is the Market Cap of Orchid Pharma ?

The Market Cap of Orchid Pharma is ₹2892 Cr As on 30 November, 2023 | 05:27

What is the P/E ratio of Orchid Pharma ?

The P/E ratio of Orchid Pharma is 30.1 As on 30 November, 2023 | 05:27

What is the PB ratio of Orchid Pharma ?

The PB ratio of Orchid Pharma is 4.2 As on 30 November, 2023 | 05:27

Q2FY23